[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,(03):10-12.[doi:10.3969/j.issn.1006-1959.2018.03.004]
 YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,(03):10-12.[doi:10.3969/j.issn.1006-1959.2018.03.004]
点击复制

胃癌中lncRNAs的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年03期
页码:
10-12
栏目:
肿瘤专题
出版日期:
2018-02-01

文章信息/Info

Title:
Research Progress of lncRNAs in Gastric Cancer
文章编号:
1006-1959(2018)03-0010-03
作者:
尹晓华12刘重元1黄 琳3罗苇如4肖 玄4张志伟1
1.南华大学医学院肿瘤研究所/肿瘤细胞与分子病理学湖南省重点实验室,湖南 衡阳 421001;2.湘南学院基础医学院生物化学教研室,湖南 郴州 423000;3.邵阳医学高等专科学校附属医院儿科,湖南 邵阳 422000;4.南华大学医学院临床医学卓越医师班,湖南 衡阳 421001
Author(s):
YIN Xiao-hua12LIU Zhong-yuan1HUANG Lin3LUO Wei-ru4XIAO Xuan4ZHANG Zhi-wei1
1.Institute of Oncology,Key Laboratory of Tumor Cell and Molecular Pathology,School of Medicine,Nanhua University,Hengyang 421001,Hunan;China;2.Department of Biochemistry,College of Basic Medicine,Xiangnan University,Chenzhou 423000,Hunan,China;3.Department of Pediatrics,Shaoyang Medical College Affiliated Hospital,Shaoyang 422000,Hunan,China;4.Department of Clinical Medical Excellence,School of Medicine,Nanhua University,Hengyang 421001,Hunan,China
关键词:
胃癌lncRNAs生物标志物表达调控
Keywords:
Gastric cancerlncRNAsBiomarkersRegulation of expression
分类号:
R318
DOI:
10.3969/j.issn.1006-1959.2018.03.004
文献标志码:
A
摘要:
胃癌是一种我国最常见的消化道恶性肿瘤,严重威胁人们健康与生命。阐明胃癌发病的分子机制及获得新的分子靶点对胃癌防治尤为重要。长链非编码RNAs的发现对深入阐明胃癌发病的分子机制及发现新的分子标志物提供了可能。本文对lncRNAs在胃癌中的表达以及对胃癌的生长增殖、转移、耐药与预后等研究进行综述。
Abstract:
Gastric cancer is one of the most common gastrointestinal malignancies in our country,which seriously threatens people’s health and life.To clarify the molecular mechanism of gastric cancer and obtain new molecular targets for the prevention and treatment of gastric cancer is particularly important.The discovery of long non-coding RNAs has made it possible to further elucidate the molecular mechanism of gastric cancer and find new molecular markers.In this paper,the expression of lncRNAs in gastric cancer and the growth,proliferation,metastasis,drug resistance and prognosis of gastric cancer were reviewed.

参考文献/References:

[1]Li M,Wang Y,Cheng L,et al.Long non-coding RNAs in renal cell carcinoma:A systematic review and clinical implications[J].Oncotarget.2017,8(29):48424-48435.
[2]Xu T P,Huang M D,Xia R,et al.Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression[J].J Hematol Oncol.2014,7(1):63.
[3]Li H,Yu B,Li J,et al.Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer[J].Oncotarget.2014,5(8):2318-2329.
[4]Zhuang M,Gao W,Xu J,et al.The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1[J].Biochem Biophys Res Commun.2014,448(3):315-322.
[5]Li T,Mo X,Fu L,et al.Molecular mechanisms of long noncoding RNAs on gastric cancer[J].Oncotarget.2016,7(8):8601-8612.
[6]Kong R,Zhang E B,Yin D D,et al.Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16[J].Mol Cancer.2015,14(1):82.
[7]Peng W,Wu G,Fan H,et al.Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer[J].Tumour Biol.2015,36(9):1-8.
[8]Yang F,Xue X,Zheng L,et al.Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability[J].FEBS J.2014,281(3):802-813.
[9]Zhang Y,Song X,Wang X,et al.Silencing of LncRNA HULC Enhances Chemotherapy Induced Apoptosis in Human Gastric Cancer[J].J Med Biochem.2016,35(2):137-143.
[10]Zhang E B,Kong R,Yin D D,et al.Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99amiR-449a[J].Oncotarget.2014,5(8):2276-2292.
[11]Qi P,Xu M D,Shen X H,et al.Reciprocal repression between TUSC7 and miR-23b in gastric cancer[J].Int J Cancer.2015,137(6):269-1278.
[12]Xu C,Shao Y,Xia T,et al.lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis[J].Tumour Biol.2014,35(10):9701-9706.
[13]Sun W,Yang Y,Xu C,et al.Roles of long noncoding RNAs in gastric cancer and their clinical applications[J].J Cancer Res Clin Oncol.2016,142(11):2231-2237.
[14]Hu Y,Pan J,Wang Y,et al.Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor prooncogenic activity in gastric cancer[J].Int J Clin Exp Pathol.2015,8(1):594-600.
[15]Yan Y,Shen Z,Gao Z,et al.Long noncoding ribonucleic acid specific for distant metastasis of gastric cancer is associated with TRIM16 expression and facilitates tumor cell invasion in vitro[J].J Gastroenterol Hepatol.2015,30(9):1367-1375.
[16]Zhuang JJ,Yue M,Zheng YH,et al.Long non-coding RNA MVIH acts as a prognostic marker in glioma and its role in cell migration and invasion[J].Eur Rev Med Pharmacol Sci.2016,20(23):4898-4904.
[17]Wang Y,Zhang D,Wu K,et al.Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines[J].Mol Cell Biol.2014,34(17):3182-3193.
[18]Hang Q1,Sun R,Jiang C,et al.Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression[J].Anticancer Drugs.2015,26(6):632-640.
[19]Yang P,Chen T,Xu Z,et al.Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO[J].Oncotarget.2016,7(27):42183-42194.

相似文献/References:

[1]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
 RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[2]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
 DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Medical Information,2018,(03):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[3]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
 PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Medical Information,2018,(03):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[4]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
 LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,(03):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[5]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
 LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Medical Information,2018,(03):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[6]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
 MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Medical Information,2018,(03):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[7]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
 ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Medical Information,2018,(03):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[8]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
 WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,(03):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[9]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息,2019,(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
 NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Medical Information,2019,(03):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
[10]张 印,张 军.进展期胃癌淋巴结清扫研究进展[J].医学信息,2019,(07):57.[doi:10.3969/j.issn.1006-1959.2019.07.018]
 ZHANG Yin,ZHANG Jun.Progress in Lymph Node Dissection of Advanced Gastric Carcinoma[J].Medical Information,2019,(03):57.[doi:10.3969/j.issn.1006-1959.2019.07.018]

更新日期/Last Update: 2018-02-01